Uniza Group

Uniza is part of the $150 M+ Pashupati group of companies. It has carved out a niche in India Business, International Business, and the Manufacturing of tablets, capsules, creams, and ointments. In its India business, the company has a distribution network and presence in 28 states with over 1500 stockists and 150+ brands across four therapies namely Dermatology, Cardio-Diabetic, Gynaecology and Respiratory. Since its inception in 2020, Uniza has strategically established its presence in Southeast Asian, African and Latin American Markets and has filed dossiers in over 30 countries, with over 300+ filings and 350+ products developed in its state-of-the-art formulations and development lab. The manufacturing unit of the company has received the following approvals: WHO GMP, Iraq, Tanzania, Ethiopia, Philippines, Kenya, Uganda, Ghana, Nigeria, Peru, Cambodia and Yemen. Uniza has developed a strong portfolio of products ranging in therapies of Cardiovascular, Anti Epileptic, Antihypertensive, Narcotics, Nephrology, Pain management, Gynaecology, Respiratory, Ophthalmics and Dermatology.